摘要
目的 评估氟铁龙在治疗与预防膀胱肿瘤中的临床价值。方法 将 10 3例膀胱肿瘤患者随机分成口服氟铁龙预防肿瘤复发组、治疗性口服氟铁龙组、膀胱内灌注丝裂霉素组和对照组 ,进行随访观察。结果 氟铁龙组复发率为 8.8% ,丝裂霉素组复发率为 12 .5 % ,两组比较差异无显著性意义 (P>0 .0 5 ) ;而与对照组复发率(40 % )比较差异有显著性意义 (P<0 .0 1)。氟铁龙治疗膀胱癌的有效率为 33.3%。结论 氟铁龙能有效地治疗和预防膀胱肿瘤的复发 ,毒副反应低 ,使用方便 ,易于临床推广。
Objective To inquire into the value of oral furtulon therapy for bladder tumors. Methods 103 patients were randomized into four groups and have been undergoing a long termfollow ups. Results Recurrent rate of oral furtulon therapy for bladder tumors (8 8%) and instillation of mitomycin C for preventing the recurrence of bladder tumors (12 5%) as compared to recurrent rate of control group(40%),which was statistically significant( P<0 01) .Overall,4 patients(33 3%) had an effective response with furtulon. Conclusions Furtulon has more effective for treatment and prophylaxis of bladder tumors.
出处
《中国医学科学院学报》
CAS
CSCD
北大核心
2000年第1期79-81,共3页
Acta Academiae Medicinae Sinicae
